EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of Epsins in atherosclerosis: From molecular mechanisms to therapeutic applications

Siarhei A Dabravolski, Alexey V Churov, Alessio L Ravani, Amina E Karimova, Igor G Luchinkin, Vasily N Sukhorukov, Alexander N Orekhov

Vascular Pharmacology · 2025

DOI: 10.1016/j.vph.2024.107457 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vascular Pharmacology, 2025. Verfasst von Siarhei A Dabravolski und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology Engineering, Braude Academic College of Engineering, Snunit 51, P.O. Box 78, Karmiel 2161002, Israel. Electronic address:…. Hauptthemen laut MEDLINE: Atherosclerosis, Adaptor Proteins, Vesicular Transport, Arteries. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is a multifaceted disease characterised by chronic inflammation and vascular remodelling, leading to plaque formation and cardiovascular complications. Recent evidence highlights the critical role of epsins, a family of endocytic proteins, in the pathogenesis of atherosclerosis. This manuscript explores the multifarious functions of epsins in atherosclerosis, focusing on their involvement in angiogenesis, lymphangiogenesis, and the modulation of key signalling pathways. We discuss how epsins facilitate EndoMT through their interaction with the TGFβ signalling pathway, which contributes to vascular smooth muscle cell-like phenotypes and plaque instability. Additionally, we examine the therapeutic potential of targeting epsins, elucidating their interactions with crucial partners such as LDLR, LRP-1, and TLR 2/4, among others, in mediating lipid metabolism and inflammation. Furthermore, we highlight the promising prospects of epsin-targeting peptides and small interfering RNAs as therapeutic agents for atherosclerosis treatment. Despite these advancements, the research faces limitations, including a reliance on specific mouse models and a need for comprehensive studies on the long-term effects of epsin modulation. Therefore, future investigations should focus on elucidating the detailed mechanisms of epsin function and their implications in cardiovascular health, fostering collaborations to translate basic research into innovative therapeutic strategies. This work underscores the necessity for further exploration of epsins to unlock their full therapeutic potential in combating atherosclerosis and related cardiovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisAdaptor Proteins, Vesicular TransportArteriesAnimalsHumansSignal TransductionPlaque, AtheroscleroticNeovascularization, PathologicLymphangiogenesisVascular Remodeling

Stichwörter der Autor:innen

AngiogenesisAtherosclerosisEpsinsInflammationLymphangiogenesis

Substanzen

Adaptor Proteins, Vesicular Transportepsin

Autor:innen und Institutionen

  • Department of Biotechnology Engineering, Braude Academic College of Engineering, Snunit 51, P.O. Box 78, Karmiel 2161002, Israel. Electronic address: sergedobrowolski@gmail.com.
  • Institute of General Pathology and Pathophysiology, 8 Baltiyskaya Street, Moscow 125315, Russia; Pirogov Russian National Research Medical University, Russia Gerontology Clinical Research Centre, Moscow, Institute on Ag…
  • Institute for Atherosclerosis Research, Osennyaya Street 4-1-207, 121609 Moscow, Russia.
  • Faculty of Biology and Biotechnology, National Research University Higher School of Economics, 33, Profsoyuznaya Street, Building 4, 117418 Moscow, Russia.
  • Institute of General Pathology and Pathophysiology, 8 Baltiyskaya Street, Moscow 125315, Russia.
  • Institute of General Pathology and Pathophysiology, 8 Baltiyskaya Street, Moscow 125315, Russia; Institute of Human Morphology, Petrovsky Russian National Center of Surgery, 2 Abrikosovsky Lane, 119991 Moscow, Russia.

Förderung

  • Russian Science Foundation

Zitieren

APA

Dabravolski, S. A., Churov, A. V., Ravani, A. L., Karimova, A. E., Luchinkin, I. G., Sukhorukov, V. N., & Orekhov, A. N. (2025). The role of Epsins in atherosclerosis: From molecular mechanisms to therapeutic applications. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2024.107457

Vancouver

Dabravolski SA, Churov AV, Ravani AL, Karimova AE, Luchinkin IG, Sukhorukov VN, et al. The role of Epsins in atherosclerosis: From molecular mechanisms to therapeutic applications. Vascular Pharmacology. 2025. doi:10.1016/j.vph.2024.107457

BibTeX
@article{Dabravolski2025,
  author = {Dabravolski, Siarhei A and Churov, Alexey V and Ravani, Alessio L and Karimova, Amina E and Luchinkin, Igor G and Sukhorukov, Vasily N and Orekhov, Alexander N},
  title = {The role of Epsins in atherosclerosis: From molecular mechanisms to therapeutic applications},
  journal = {Vascular Pharmacology},
  year = {2025},
  doi = {10.1016/j.vph.2024.107457}
}
Kostenlos starten →